OTCMKTS:ETST

Earth Science Tech Competitors

$0.03
-0.01 (-17.77 %)
(As of 04/14/2021 03:58 PM ET)
Add
Compare
Today's Range
$0.03
Now: $0.03
$0.03
50-Day Range
$0.03
MA: $0.04
$0.07
52-Week Range
$0.01
Now: $0.03
$0.10
Volume218,875 shs
Average Volume452,200 shs
Market Capitalization$1.40 million
P/E RatioN/A
Dividend YieldN/A
Beta2.53

Competitors

Earth Science Tech (OTCMKTS:ETST) Vs. WCUI, KAYS, IPCIF, ISCO, BCTXF, and FWDG

Should you be buying ETST stock or one of its competitors? Companies in the industry of "pharmaceutical preparations" are considered alternatives and competitors to Earth Science Tech, including Wellness Center USA (WCUI), Kaya (KAYS), Intellipharmaceutics International (IPCIF), International Stem Cell (ISCO), BriaCell Therapeutics (BCTXF), and FutureWorld (FWDG).

Wellness Center USA (OTCMKTS:WCUI) and Earth Science Tech (OTCMKTS:ETST) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, earnings, profitability, dividends, analyst recommendations and institutional ownership.

Analyst Recommendations

This is a summary of current recommendations and price targets for Wellness Center USA and Earth Science Tech, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Wellness Center USA0000N/A
Earth Science Tech0000N/A

Volatility and Risk

Wellness Center USA has a beta of 0.57, suggesting that its stock price is 43% less volatile than the S&P 500. Comparatively, Earth Science Tech has a beta of 2.53, suggesting that its stock price is 153% more volatile than the S&P 500.

Insider & Institutional Ownership

0.1% of Wellness Center USA shares are owned by institutional investors. 14.1% of Wellness Center USA shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Profitability

This table compares Wellness Center USA and Earth Science Tech's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Wellness Center USAN/AN/A-1,809.19%
Earth Science Tech-1,750.31%N/A-2,929.76%

Earnings & Valuation

This table compares Wellness Center USA and Earth Science Tech's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Wellness Center USA$30,000.00213.00$-2,390,000.00N/AN/A
Earth Science Tech$530,000.002.64$-1,200,000.00N/AN/A

Earth Science Tech has higher revenue and earnings than Wellness Center USA.

Summary

Wellness Center USA beats Earth Science Tech on 5 of the 8 factors compared between the two stocks.

Earth Science Tech (OTCMKTS:ETST) and Kaya (OTCMKTS:KAYS) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, risk, dividends, institutional ownership, analyst recommendations, earnings and valuation.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Earth Science Tech and Kaya, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Earth Science Tech0000N/A
Kaya01002.00

Earnings and Valuation

This table compares Earth Science Tech and Kaya's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Earth Science Tech$530,000.002.64$-1,200,000.00N/AN/A
Kaya$1.01 million6.17$7.80 millionN/AN/A

Kaya has higher revenue and earnings than Earth Science Tech.

Profitability

This table compares Earth Science Tech and Kaya's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Earth Science Tech-1,750.31%N/A-2,929.76%
Kaya-1,558.07%N/A-586.93%

Risk & Volatility

Earth Science Tech has a beta of 2.53, suggesting that its stock price is 153% more volatile than the S&P 500. Comparatively, Kaya has a beta of 0.28, suggesting that its stock price is 72% less volatile than the S&P 500.

Summary

Kaya beats Earth Science Tech on 5 of the 6 factors compared between the two stocks.

Earth Science Tech (OTCMKTS:ETST) and Intellipharmaceutics International (OTCMKTS:IPCIF) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, risk, dividends, institutional ownership, analyst recommendations, earnings and valuation.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Earth Science Tech and Intellipharmaceutics International, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Earth Science Tech0000N/A
Intellipharmaceutics International0000N/A

Earnings and Valuation

This table compares Earth Science Tech and Intellipharmaceutics International's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Earth Science Tech$530,000.002.64$-1,200,000.00N/AN/A
Intellipharmaceutics International$3.48 million1.57$-8,090,000.00N/AN/A

Earth Science Tech has higher earnings, but lower revenue than Intellipharmaceutics International.

Profitability

This table compares Earth Science Tech and Intellipharmaceutics International's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Earth Science Tech-1,750.31%N/A-2,929.76%
Intellipharmaceutics International-232.11%N/A-81.71%

Risk & Volatility

Earth Science Tech has a beta of 2.53, suggesting that its stock price is 153% more volatile than the S&P 500. Comparatively, Intellipharmaceutics International has a beta of 1.36, suggesting that its stock price is 36% more volatile than the S&P 500.

Earth Science Tech (OTCMKTS:ETST) and International Stem Cell (OTCMKTS:ISCO) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, risk, dividends, institutional ownership, analyst recommendations, earnings and valuation.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Earth Science Tech and International Stem Cell, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Earth Science Tech0000N/A
International Stem Cell0000N/A

Earnings and Valuation

This table compares Earth Science Tech and International Stem Cell's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Earth Science Tech$530,000.002.64$-1,200,000.00N/AN/A
International Stem Cell$9.47 million0.57$-4,260,000.00N/AN/A

Earth Science Tech has higher earnings, but lower revenue than International Stem Cell.

Profitability

This table compares Earth Science Tech and International Stem Cell's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Earth Science Tech-1,750.31%N/A-2,929.76%
International Stem Cell-55.56%N/A-72.21%

Risk & Volatility

Earth Science Tech has a beta of 2.53, suggesting that its stock price is 153% more volatile than the S&P 500. Comparatively, International Stem Cell has a beta of 1.03, suggesting that its stock price is 3% more volatile than the S&P 500.

Earth Science Tech (OTCMKTS:ETST) and BriaCell Therapeutics (OTCMKTS:BCTXF) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, risk, dividends, institutional ownership, analyst recommendations, earnings and valuation.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Earth Science Tech and BriaCell Therapeutics, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Earth Science Tech0000N/A
BriaCell Therapeutics0000N/A

Earnings and Valuation

This table compares Earth Science Tech and BriaCell Therapeutics' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Earth Science Tech$530,000.002.64$-1,200,000.00N/AN/A
BriaCell TherapeuticsN/AN/A$-3,680,000.00N/AN/A

Earth Science Tech has higher revenue and earnings than BriaCell Therapeutics.

Profitability

This table compares Earth Science Tech and BriaCell Therapeutics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Earth Science Tech-1,750.31%N/A-2,929.76%
BriaCell TherapeuticsN/AN/A-786.77%

Volatility & Risk

Earth Science Tech has a beta of 2.53, meaning that its stock price is 153% more volatile than the S&P 500. Comparatively, BriaCell Therapeutics has a beta of 1.14, meaning that its stock price is 14% more volatile than the S&P 500.

Insider & Institutional Ownership

0.1% of BriaCell Therapeutics shares are held by institutional investors. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Earth Science Tech (OTCMKTS:ETST) and FutureWorld (OTCMKTS:FWDG) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, risk, dividends, institutional ownership, analyst recommendations, earnings and valuation.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Earth Science Tech and FutureWorld, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Earth Science Tech0000N/A
FutureWorld0000N/A

Earnings and Valuation

This table compares Earth Science Tech and FutureWorld's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Earth Science Tech$530,000.002.64$-1,200,000.00N/AN/A
FutureWorldN/AN/AN/AN/AN/A

FutureWorld has lower revenue, but higher earnings than Earth Science Tech.

Profitability

This table compares Earth Science Tech and FutureWorld's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Earth Science Tech-1,750.31%N/A-2,929.76%
FutureWorldN/AN/AN/A

Risk & Volatility

Earth Science Tech has a beta of 2.53, suggesting that its stock price is 153% more volatile than the S&P 500. Comparatively, FutureWorld has a beta of 0.73, suggesting that its stock price is 27% less volatile than the S&P 500.


Earth Science Tech Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Wellness Center USA logo
WCUI
Wellness Center USA
0.5$0.06-0.0%$6.39 million$30,000.000.00
KAYS
Kaya
0.7$0.43-0.0%$6.23 million$1.01 million0.00Gap Up
Intellipharmaceutics International logo
IPCIF
Intellipharmaceutics International
0.6$0.23-4.3%$5.46 million$3.48 million-1.92News Coverage
International Stem Cell logo
ISCO
International Stem Cell
0.8$0.72-4.2%$5.43 million$9.47 million0.00
BCTXF
BriaCell Therapeutics
0.0N/AN/A$4.59 millionN/A-0.01
FutureWorld logo
FWDG
FutureWorld
0.5$0.00-0.0%$4.56 millionN/A0.00
American Bio Medica logo
ABMC
American Bio Medica
0.5$0.11-0.0%$4.38 million$3.65 million0.00Decrease in Short Interest
Gap Up
AMBS
Amarantus BioScience
0.0$0.01-0.0%$4.05 millionN/A0.00Increase in Short Interest
AKRXQ
Akorn
0.1$0.03-0.0%$3.60 million$682.43 million-0.01
VG Life Sciences logo
VGLS
VG Life Sciences
0.0$0.01-0.0%$3.50 millionN/A0.00Increase in Short Interest
Immune Pharmaceuticals logo
IMNPQ
Immune Pharmaceuticals
0.0$0.17-12.1%$3.47 millionN/A0.00High Trading Volume
Increase in Short Interest
Gap Up
INNVD
Innovus Pharmaceuticals
0.6N/AN/A$2.90 million$23.99 million-0.72Gap Down
RSPI
RespireRx Pharmaceuticals
0.5$0.04-0.0%$2.84 millionN/A-0.09
NSPX
Inspyr Therapeutics
0.5$0.02-0.0%$2.31 millionN/A0.00Gap Down
Boston Therapeutics logo
BTHE
Boston Therapeutics
0.5$0.02-0.0%$2.16 million$20,000.00-0.97News Coverage
Gap Up
IMUCD
ImmunoCellular Therapeutics
0.0$0.51-5.9%$2.14 millionN/A0.00Gap Up
VVUSQ
VIVUS
0.6$0.12-0.0%$2.10 million$69.76 million-0.04
Capstone Therapeutics logo
CAPS
Capstone Therapeutics
0.8$36.01-0.0%$1.95 million$2 million0.00News Coverage
WWHC
W World
0.8$6.09-0.0%$1.80 millionN/A0.00Increase in Short Interest
ImmunoCellular Therapeutics logo
IMUC
ImmunoCellular Therapeutics
0.0$0.51-5.9%$1.80 millionN/A0.00Gap Up
Cardax logo
CDXI
Cardax
0.0$2.00-5.0%$1.59 million$710,000.000.00Gap Up
AOXG
Aoxing Pharmaceutical
0.5$0.02-50.0%$1.52 millionN/A0.00Gap Up
MLNTQ
Melinta Therapeutics
0.2$0.11-0.0%$1.51 million$96.43 million0.00
Achaogen logo
AKAOQ
Achaogen
0.6$0.03-0.0%$1.30 million$8.73 million0.00Gap Up
Cotinga Pharmaceuticals logo
COTQF
Cotinga Pharmaceuticals
0.4$0.05-0.0%$1.12 millionN/A-0.57High Trading Volume
Decrease in Short Interest
AOLS
Aeolus Pharmaceuticals
0.8$0.01-0.0%$1.07 millionN/A0.00Increase in Short Interest
Gap Up
Propanc Biopharma logo
PPCB
Propanc Biopharma
0.7$0.21-4.8%$1.03 millionN/A0.00Decrease in Short Interest
Gap Up
Anthera Pharmaceuticals logo
ANTH
Anthera Pharmaceuticals
0.5$0.07-0.0%$970,000.00N/A0.00Increase in Short Interest
News Coverage
Gap Up
SPHS
Sophiris Bio
0.1$0.03-0.0%$965,000.00N/A0.00Increase in Short Interest
Gap Up
TetraLogic Pharmaceuticals logo
TLOG
TetraLogic Pharmaceuticals
0.5$0.04-26.3%$941,000.00N/A0.00Gap Up
ATRX
Adhera Therapeutics
0.0$0.08-0.0%$872,000.00$250,000.000.00
Spotlight Innovation logo
STLT
Spotlight Innovation
0.5$0.02-0.0%$772,000.00N/A0.00
Sienna Biopharmaceuticals logo
SNNAQ
Sienna Biopharmaceuticals
0.5$0.02-36.3%$749,000.00N/A0.00Gap Up
PXYN
Praxsyn
0.6$0.00-20.0%$678,000.00N/A0.00Increase in Short Interest
Gap Down
SKVI
Skinvisible
0.7$0.15-0.0%$671,000.00$40,000.000.00
Argos Therapeutics logo
ARGSQ
Argos Therapeutics
0.6$0.05-0.0%$572,000.00$1.90 million0.00
TRPXD
Therapix Biosciences
0.0$9.20-0.5%$460,000.00N/A0.00High Trading Volume
BSPM
Biostar Pharmaceuticals
0.0$0.17-0.0%$436,000.00N/A0.00
HSTC
HST Global
0.8$0.07-0.0%$378,000.00N/A0.00
ProMetic Life Sciences logo
PFSCF
ProMetic Life Sciences
0.5$5.47-3.7%$338,000.00$36.55 million0.00News Coverage
Gap Up
EPRSQ
EPIRUS Biopharmaceuticals
0.5$0.01-0.0%$319,000.00N/A0.00Increase in Short Interest
Gap Down
PZRXQ
PhaseRx
0.2$0.03-0.0%$298,000.00N/A0.00Decrease in Short Interest
WDBG
Woodbrook Group
0.0$1.60-0.0%$224,000.00N/A0.00
ROSGQ
Rosetta Genomics
0.0$0.09-5.9%$124,000.00N/A0.00Gap Up
MetaStat logo
MTST
MetaStat
0.0$0.02-0.0%$118,000.00$20,000.000.00
OREXQ
Orexigen Therapeutics
0.4$0.01-26.4%$100,000.00$33.71 million0.00Gap Up
AXMP
AXM Pharma
0.2$0.00-0.0%$81,000.00N/A0.00
ALSE
Alseres Pharmaceuticals
0.0$6.00-0.0%$36,000.00N/A0.00
BOPH
Bohai Pharmaceuticals Group
0.5$0.00-0.0%$20,000.00N/A0.00
Immune Therapeutics logo
IMUN
Immune Therapeutics
0.6$0.02-0.0%$8,000.00$110,000.000.00Decrease in Short Interest
This page was last updated on 4/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.